Holista CollTech (ASX:HCT) Current Deferred Revenue: A$0.26 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Holista CollTech Current Deferred Revenue?

Holista CollTech ASX:HCT Current Deferred Revenue is A$0.26 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Holista CollTech's current deferred revenue for the quarter that ended in Dec. 2025 was A$0.26 Mil.

Holista CollTech Current Deferred Revenue Related Terms

Holista CollTech Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Holista CollTech's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Holista CollTech Current Deferred Revenue Chart

Holista CollTech Annual Data
Trend Jun16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.05 0.06 0.56 0.26

Holista CollTech Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.00 0.56 0.00 0.26
What does a Current Deferred Revenue of A$0.26 Mil mean?
Holista CollTech (ASX:HCT) has a Current Deferred Revenue of A$0.26 Mil as of Dec. 2025. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Holista CollTech and its competitors.
Is Holista CollTech's Current Deferred Revenue too high?
Holista CollTech's current Current Deferred Revenue is A$0.26 Mil.
How does Holista CollTech's Current Deferred Revenue compare to KHC and GIS?
Holista CollTech's Current Deferred Revenue of A$0.26 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Consumer Packaged Goods company?
A good Current Deferred Revenue depends on the Consumer Packaged Goods industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Holista CollTech and its competitors. Holista CollTech's current Current Deferred Revenue is A$0.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Holista CollTech stock overvalued right now?
Based on GuruFocus' analysis, Holista CollTech (ASX:HCT) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.08 — trading 700% above its estimated fair value. The current Current Deferred Revenue is A$0.26 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Holista CollTech (ASX:HCT), the current Current Deferred Revenue is A$0.26 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Holista CollTech Business Description

Address 283 Rokeby Road, Subiaco, Perth, WA, AUS, 6008
Holista CollTech Ltd is a research-driven biotech company. Its operating segments include Supplements; Ovine Collagen; Infection Control Solutions; Food Ingredients; and Corporate. The supplements segment is involved in the manufacturing and wholesale distribution of dietary supplements. The ovine collagen segment is involved in the manufacturing and distribution of cosmetic grade collagen. The food ingredients segment is involved in the manufacturing and wholesale distribution of healthy food ingredients. The infection control segment is involved in the infection control solutions. The company generates a majority of its revenue from the Supplements segment. Geographically, it generates a majority of its revenue from Malaysia and the rest from Australia and the United States.